Vectorized conjugates of monoclonal antibodies: Diagnostic and therapeutic applications

Monoclonal antibodies (mAbs) have revolutionized the landscape of cancer treatment with indispensable applications in various malignancies. This poster, presented at the SelectScience^® Virtual Cancer and Immunology Research Summit 2022, displays an adaptable rebridging (conjugation) approach to develop a new format of mAbs conjugates (biomodified) with a multitude of applications.